The investor pages that follow are your resource for financial information about Medivation, Inc.
Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel therapies to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their families.
May 13, 2013
Medivation Names Stephen Kelsey Senior Vice President of New Projects
May 09, 2013
Medivation Reports First Quarter Financial Results and Provides Corporate Update
May 06, 2013
Medivation Announces Participation at Upcoming Investor Conferences
May 29, 2013 at 4:50 PM ET
38th Annual dbAccess Health Care Conference
Jun 3, 2013 at 11:00 AM ET
Jefferies 2013 Global Healthcare Conference
For Investors
investors@medivation.com
For Media
media@medivation.com